Bausch Health (BHC) Companies announced the commercial expansion of OraPharma into Canada and Puerto Rico. This strategic move reflects OraPharma’s commitment to improving oral health awareness, providing access to treatments within periodontal disease management, and strengthening partnerships with local distributors and dental professionals in these markets.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHC:
- Closing Bell Movers: Meta sinks, Alphabet jumps after earnings
- Bausch Health reports Q3 revenue $2.68B, consensus $2.63B
- Bausch Health sees FY25 revenue $10.05B-$10.25B, consensus $10.12B
- Bausch Health options imply 8.2% move in share price post-earnings
- Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge